Island Pharmaceuticals LtdASX: ILA

Annual General Meeting - Rescheduled Date

Sep 29, 2026 at 9:53 PM EDT · Issued by Island Pharmaceuticals Ltd via ASX

Filed with ASX · Sep 29, 2026 at 9:53 PM EDT

On 6ix: 6ix.com/news/annual-general-meeting-rescheduled-date

Island Pharmaceuticals Limited ACN 641 183 842 | Registered office: Level 1 Suite 1, 117 Camberwell Road, Hawthorn East VIC 3123 Australia Page 1 of 2 30 September 2026 ASX Announcement ANNUAL GENERAL MEETING – RESCHEDULED DATE MELBOURNE, Australia, 30 September 2026: Australian...

View Attachment

6ix hasn’t read this filing yet.

Island Pharmaceuticals Ltd on 6ix

Earlier from Island Pharmaceuticals

Pivotal Marburg data secured for Galidesivir FDA pathwayAug 30
Appendix 4G and Corporate Governance StatementAug 26
Annual Report to shareholdersAug 26
Preliminary Final ReportAug 26
Island boosts Galidesivir supply as Ebola surgesAug 20

Later from Island Pharmaceuticals

Galidesivir GMP manufacturing commencesOct 1
Notification regarding unquoted securities - ILAOct 8
USAMRIID Marburg study advances towards dosingOct 18
Letter to Shareholders, Notice of AGM & Proxy FormOct 22
Quarterly Appendix 4C and Activities ReportOct 25

All Island Pharmaceuticals news releases

Follow Island Pharmaceuticals into a list and get an email when it puts out news.

Follow Island Pharmaceuticals